Cargando…
In vivo evaluation of an innovative synbiotics on stage IIIb-IV chronic kidney disease patients
BACKGROUND: Microbiota unbalance has been proven to affect chronic kidney disease (CKD) patients and, noteworthy, microbiota composition and activity are implicated in CKD worsening. The progression of kidney failure implies an exceeding accumulation of waste compounds deriving from the nitrogenous...
Autores principales: | Vacca, Mirco, Celano, Giuseppe, Calabrese, Francesco Maria, Rocchetti, Maria Teresa, Iacobellis, Ilaria, Serale, Nadia, Calasso, Maria, Gesualdo, Loreto, De Angelis, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311028/ https://www.ncbi.nlm.nih.gov/pubmed/37396126 http://dx.doi.org/10.3389/fnut.2023.1215836 |
Ejemplares similares
-
An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients
por: Cosola, Carmela, et al.
Publicado: (2021) -
In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients
por: Vacca, Mirco, et al.
Publicado: (2021) -
Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy
por: Lauriero, Gabriella, et al.
Publicado: (2021) -
How Metabolomics Provides Novel Insights on Celiac Disease and Gluten-Free Diet: A Narrative Review
por: Vacca, Mirco, et al.
Publicado: (2022) -
Ketoanalogs’ Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study)
por: Rocchetti, Maria Teresa, et al.
Publicado: (2021)